Dr. Somya Ranjan Dash

About

My area of research revolves around nanotechnology and cancer stem cell biology and I have been working on the development of a chemotherapeutic regimen through the investigation of the mechanism of action of a novel hybrid nanoparticle in combination with the photothermal therapy.

Employment

• Adesh University Assistant Professor
  2026 - Present
• Indian Institute of Science Education and Research Berhampur DBT-Postdoctoral Fellow
  2025 - 2026
• IISER Berhampur Postdoctoral Research Fellow
  2024 - 2025
• Cornell University Postdoctoral Research Associate
  2024 - 2024

Education

• KIIT School of Biotechnology PhD in Cancer Biology
  2018 - 2024
• Utkal University M.Sc Biotechnology
  2016 - 2018
• Utkal University B.Sc Biotechnology
  2013 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (27)

• Harnessing Nanotechnology to Rewire Lipid Metabolism: A Novel Therapeutic Avenue for Brain Cancer
  Molecular Pharmaceutics 2026 DOI: 10.1021/acs.molpharmaceut.5c01091
  +Save
• Metabolic Cross Talk in the Tumor Microenvironment
  Cancer Treatment and Research 2026 DOI: 10.1007/978-3-032-21861-2_7
  +Save
• 5-FU in combination with PARP inhibitor ABT-888 deregulates MGMT-dependent mismatch repair (MMR) pathway in MMR-proficient colorectal cancer stem cells by modulating MGMT/PARP1/MSH6 complex
  Expert Opinion on Therapeutic Targets 2026 DOI: 10.1080/14728222.2026.2706483
  +Save
• Nanoparticles based Therapeutics Approaches for Cancer
  Materials Research Foundations 2024 DOI: 10.21741/9781644903339-2
  +Save
• Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation
  Medical Oncology 2024 DOI: 10.1007/s12032-023-02279-0
  +Save
• Determining the effect of long non-coding RNA maternally expressed gene 3 (lncRNA MEG3) on the transcriptome profile in cervical cancer cell lines
  Genomics 2024 DOI: 10.1016/j.ygeno.2024.110957
  +Save
• Nano formulated Resveratrol inhibits PD-L1 in oral cancer cells by deregulating the association between tumor associated macrophages and cancer associated fibroblasts through IL-6/JAK2/STAT3 signaling axis
  Journal of Nutritional Biochemistry 2024 DOI: 10.1016/j.jnutbio.2024.109568
  +Save
• Near infrared-responsive quinacrine–gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells
  Nanomedicine 2024 DOI: 10.2217/nnm-2023-0269
  +Save
• The role of viruses in cancer progression versus cancer treatment: A dual paradigm
  Life Sciences 2024 DOI: 10.1016/j.lfs.2024.122506
  +Save
• Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells
  Phytomedicine 2023 DOI: 10.1016/j.phymed.2023.154914
  +Save